Jonathan Cotliar - 25 Oct 2021 Form 4 Insider Report for Science 37 Holdings, Inc.

Role
Chief Medical Officer
Signature
/s/ Christine Pellizzari, Attorney-in-Fact for Jonathan Cotliar
Issuer symbol
N/A
Transactions as of
25 Oct 2021
Net transactions value
+$41,434
Form type
4
Filing time
25 Feb 2022, 15:26:54 UTC
Previous filing
08 Oct 2021
Next filing
11 Jan 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SNCE Common Stock Options Exercise $3,857 +4,538 +0.85% $0.8500 539,879 25 Oct 2021 Direct
transaction SNCE Common Stock Options Exercise $4,978 +5,857 +1.1% $0.8500 545,736 25 Oct 2021 Direct
transaction SNCE Common Stock Options Exercise $27,230 +68,074 +12% $0.4000 613,810 28 Oct 2021 Direct
transaction SNCE Common Stock Options Exercise $830 +977 +0.16% $0.8500 614,787 02 Dec 2021 Direct
transaction SNCE Common Stock Options Exercise $4,538 +11,345 +1.8% $0.4000 626,132 02 Dec 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SNCE Stock Option Options Exercise $0 -4,538 -100% $0.000000* 0 25 Oct 2021 Common Stock 4,538 $0.8500 Direct F1
transaction SNCE Stock Option Options Exercise $0 -5,857 -55% $0.000000 4,882 25 Oct 2021 Common Stock 5,857 $0.8500 Direct F2
transaction SNCE Stock Option Options Exercise $0 -68,074 -23% $0.000000 226,920 28 Oct 2021 Common Stock 68,074 $0.4000 Direct F3, F4
transaction SNCE Stock Option Options Exercise $0 -977 -20% $0.000000 3,905 02 Dec 2021 Common Stock 977 $0.8500 Direct F5
transaction SNCE Stock Option Options Exercise $0 -11,345 -5% $0.000000 215,575 02 Dec 2021 Common Stock 11,345 $0.4000 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Stock Option was fully vested and exercisable as of the date of the transaction.
F2 Stock Option will vest in equal monthly installments until fully vested on March 7, 2022, subject to the executive's continued service through the vesting date.
F3 Stock Option will vest in equal monthly installments until fully vested on June 19, 2023, subject to the executive's continued service through the applicable vesting date.
F4 The total amount has been adjusted to add eight derivative securities that were not previously included due to a rounding error.
F5 Stock Option will vest in equal monthly installments until fully vested on March 7, 2022, subject to the executive's continued service through the applicable vesting date.
F6 Stock Option will vest in equal monthly installments until fully vested on June 19, 2023, subject to the executive's continued service through the applicable vesting date.